ALIGN TECHNOLOGY INC ALGN

Latest FY: 2025 Healthcare Medical Instruments & Supplies
Market Price $181.23
Market Cap $12.62B
P/E Ratio 32.08
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑0.9% YoY
$4.03B
3-Yr CAGR: 2.6%
Net Income ↓-2.6% YoY
$410.35M
Net Margin: 10.2%
Free Cash Flow ↓-21.2% YoY
$490.78M
FCF Yield: 3.89%
EPS (Diluted) ↑0.5% YoY
$5.65
Basic: $5.66
Return on Equity Efficiency
10.1%
ROA: 247.8%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (ALGN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $1,079.9M $815.3M $189.7M $2.33 $247.7M $177.1M
FY 2017 $1,473.4M +36.4% $1,116.9M $231.4M +22.0% $2.83 +21.5% $438.5M $242.8M +37.1%
FY 2018 $1,966.5M +33.5% $1,447.9M $400.2M +72.9% $4.92 +73.9% $554.7M $331.4M +36.5%
FY 2019 $2,406.8M +22.4% $1,743.9M $442.8M +10.6% $5.53 +12.4% $747.3M $597.6M +80.3%
FY 2020 $2,471.9M +2.7% $1,763.2M $1,775.9M +301.1% $22.41 +305.2% $662.2M $507.3M -15.1%
FY 2021 $3,952.6M +59.9% $2,935.4M $772.0M -56.5% $9.69 -56.8% $1,172.5M $771.4M +52.1%
FY 2022 $3,734.6M -5.5% $2,633.8M $361.6M -53.2% $4.61 -52.4% $568.7M $276.8M -64.1%
FY 2023 $3,862.3M +3.4% $2,706.9M $445.1M +23.1% $5.81 +26.0% $785.8M $608.1M +119.6%
FY 2024 $3,999.0M +3.5% $2,799.2M $421.4M -5.3% $5.62 -3.3% $738.2M $622.7M +2.4%
FY 2025 $4,035.0M +0.9% $2,711.0M $410.4M -2.6% $5.65 +0.5% $593.2M $490.8M -21.2%
$

Valuation

Market Price $181.23
Market Cap $12.62B
Enterprise Value N/A
P/E Ratio 32.08
P/B Ratio 3.21
FCF Yield 3.89%
Dividend Yield N/A
Shares Outstanding 71,618,100
%

Profitability & Margins

Gross Margin 67.19%
Operating Margin 13.53%
Net Margin 10.17%
Return on Equity (ROE) 10.13%
Return on Assets (ROA) 247.84%
Asset Turnover 24.37x
Revenue 3-Yr CAGR 2.61%
🛡️

Financial Health & Liquidity

Current Ratio 0.31
Cash Ratio 2.04
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $1.09B
Total Debt N/A
Book Value / Share $56.54
💧

Cash Flow Efficiency

Operating Cash Flow $593.22M
Capital Expenditures (CapEx) $102.44M
Free Cash Flow $490.78M
OCF / Revenue 14.70%
FCF / Revenue 12.16%
FCF 3-Yr CAGR 21.03%
🏷️

Per Share Metrics

EPS (Diluted) $5.65
EPS (Basic) $5.66
Dividends / Share N/A
Book Value / Share $56.54
EPS YoY Growth 0.53%
🏛️

Balance Sheet (FY 2025)

Total Assets $165.57M
Total Liabilities $536.75M
Stockholders' Equity $4.05B
Current Assets $165.57M
Current Liabilities $536.75M